Cronos Group Inc.CRONEarnings & Financial Report
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Revenue
$33.5M
Gross Profit
$14.5M
Operating Profit
$-5.3M
Net Profit
$-39.7M
Gross Margin
43.4%
Operating Margin
-15.9%
Net Margin
-118.7%
YoY Growth
20.5%
EPS
$-0.10
Cronos Group Inc. Q2 FY2025 Financial Summary
Cronos Group Inc. reported revenue of $33.5M (up 20.5% YoY) for Q2 FY2025, with a net profit of $-39.7M (down 353.5% YoY) (-118.7% margin). Cost of goods sold was $19.0M, operating expenses totaled $19.8M.
Key Financial Metrics
| Total Revenue | $33.5M |
|---|---|
| Net Profit | $-39.7M |
| Gross Margin | 43.4% |
| Operating Margin | -15.9% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
Cronos Group Inc. Q2 FY2025 revenue of $33.5M breaks down across 2 segments, led by Cannabis Flower at $25.0M (74.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Cannabis Flower | $25.0M | 74.8% |
| Cannabis Extracts | $8.4M | 25.0% |
Cronos Group Inc. Revenue by Segment — Quarterly Trend
Cronos Group Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Cannabis Flower and Cannabis Extracts) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Cannabis Flower | $33.7M | $26.4M | $25.0M | $23.3M |
| Cannabis Extracts | $10.8M | $10.0M | $8.4M | $8.6M |
Cronos Group Inc. Annual Revenue by Year
Cronos Group Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $146.6M).
| Year | Annual Revenue |
|---|---|
| 2025 | $146.6M |
| 2024 | $117.6M |
| 2023 | $87.2M |
| 2022 | $86.7M |
Cronos Group Inc. Quarterly Revenue & Net Profit History
Cronos Group Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $44.5M | +47.0% | $-1.8M | -4.1% |
| Q3 FY2025 | $36.3M | +6.1% | $26.0M | 71.4% |
| Q2 FY2025 | $33.5M | +20.5% | $-39.7M | -118.7% |
| Q1 FY2025 | $32.3M | +27.6% | $6.1M | 19.0% |
| Q4 FY2024 | $30.3M | +26.7% | $43.7M | 144.3% |
| Q3 FY2024 | $34.3M | +38.1% | $8.3M | 24.4% |
| Q2 FY2024 | $27.8M | +46.0% | $-8.8M | -31.5% |
| Q1 FY2024 | $25.3M | +29.7% | $-2.2M | -8.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.3M | $27.8M | $34.3M | $30.3M | $32.3M | $33.5M | $36.3M | $44.5M |
| YoY Growth | 29.7% | 46.0% | 38.1% | 26.7% | 27.6% | 20.5% | 6.1% | 47.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.11B | $1.09B | $1.18B | $1.17B | $1.15B | $1.18B | $1.18B | $1.20B |
| Liabilities | $35.8M | $35.3M | $52.8M | $55.3M | $39.1M | $45.0M | $46.4M | $54.2M |
| Equity | $1.08B | $1.06B | $1.08B | $1.06B | $1.07B | $1.08B | $1.08B | $1.09B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.2M | $1.7M | $11.6M | $7.7M | $-2.1M | $2.8M | $13.3M | $11.8M |